Avidity Partners Management LP
- SEC CIK
- 0001791827
- 最新申報
- 2026/8/14
2022 年第 3 季持倉
持倉截至 2022/9/30，2022/11/14 申報。只含多頭部位，變化是跟 2022 年第 2 季比股數。
- 持股檔數
- 96
- 較 2022 年第 2 季 +14
- 總值
- $46.0 億
- 較 2022 年第 2 季 +$2.41 億 (+5.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| LLYEli Lilly & Co | Stock | 1,007,000 | $3.26 億 | 7.1% | +397,000+65.1% | 加碼 | 歷史 |
| UTHRUnited Therapeutics Corp | COM | 970,200 | $2.03 億 | 4.4% | +244,600+33.7% | 加碼 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 1,855,700 | $1.97 億 | 4.3% | +388,100+26.4% | 加碼 | 歷史 |
| ARVNArvinas, Inc. | COM | 4,343,500 | $1.93 億 | 4.2% | +987,877+29.4% | 加碼 | 歷史 |
| ARGXArgenx SE | SPONSORED ADR | 491,800 | $1.74 億 | 3.8% | −80,700−14.1% | 減碼 | 歷史 |
| BIIBBiogen Inc. | COM | 600,000 | $1.60 億 | 3.5% | +159,434+36.2% | 加碼 | 歷史 |
| VRTXVertex Pharmaceuticals Inc | Stock | 512,800 | $1.48 億 | 3.2% | −280,200−35.3% | 減碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 5,586,900 | $1.34 億 | 2.9% | +136,900+2.5% | 加碼 | 歷史 |
| PRTAProthena Corp Public Ltd Co | SHS | 1,967,000 | $1.19 億 | 2.6% | +1,967,000 | 新進 | 歷史 |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 1,480,000 | $1.17 億 | 2.6% | −395,000−21.1% | 減碼 | – |
| ACHCAcadia Healthcare Company, Inc. | COM | 1,389,200 | $1.09 億 | 2.4% | +354,200+34.2% | 加碼 | 歷史 |
| AKROAkero Therapeutics, Inc. | COM | 3,122,000 | $1.06 億 | 2.3% | +3,122,000 | 新進 | 歷史 |
| SRPTSarepta Therapeutics, Inc. | COM | 948,200 | $1.05 億 | 2.3% | +948,200 | 新進 | 歷史 |
| HUMHumana Inc | Stock | 212,000 | $1.03 億 | 2.2% | −200,300−48.6% | 減碼 | 歷史 |
| BSXBoston Scientific Corp | Stock | 2,538,600 | $9,832 萬 | 2.1% | +13,600+0.5% | 加碼 | 歷史 |
| IMCRImmunocore Holdings plc | ADS | 2,079,100 | $9,759 萬 | 2.1% | +729,100+54.0% | 加碼 | 歷史 |
| KRTXKaruna Therapeutics, Inc. | COM | 431,800 | $9,713 萬 | 2.1% | +227,230+111.1% | 加碼 | 歷史 |
| ELVElevance Health, Inc. | Stock | 207,600 | $9,430 萬 | 2.1% | −233,400−52.9% | 減碼 | 歷史 |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 1,482,200 | $9,173 萬 | 2.0% | −374,700−20.2% | 減碼 | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 4,223,100 | $9,147 萬 | 2.0% | +637,219+17.8% | 加碼 | 歷史 |
| AVTRAvantor, Inc. | COM | 4,522,600 | $8,864 萬 | 1.9% | −2,130,100−32.0% | 減碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 2,051,600 | $8,496 萬 | 1.8% | +572,100+38.7% | 加碼 | 歷史 |
| NTRANatera, Inc. | COM | 1,735,000 | $7,603 萬 | 1.7% | +365,900+26.7% | 加碼 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 1,538,600 | $6,865 萬 | 1.5% | +1,538,600 | 新進 | 歷史 |
| CTLTCatalent, Inc. | COM | 940,000 | $6,802 萬 | 1.5% | −15,000−1.6% | 減碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 1,402,500 | $6,526 萬 | 1.4% | +626,996+80.9% | 加碼 | 歷史 |
| SGENSeagen Inc. | COM | 445,500 | $6,096 萬 | 1.3% | −104,500−19.0% | 減碼 | 歷史 |
| BIOBio-Rad Laboratories, Inc. | CL A | 144,800 | $6,040 萬 | 1.3% | +144,800 | 新進 | 歷史 |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 288,500 | $5,775 萬 | 1.3% | +288,500 | 新進 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 844,000 | $5,765 萬 | 1.3% | +629,000+292.6% | 加碼 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 999,100 | $5,591 萬 | 1.2% | −126,094−11.2% | 減碼 | 歷史 |
| IDYAIDEAYA Biosciences, Inc. | COM | 3,715,400 | $5,543 萬 | 1.2% | +742,453+25.0% | 加碼 | 歷史 |
| KZRKezar Life Sciences, Inc. | COM | 5,414,400 | $4,662 萬 | 1.0% | +1,364,400+33.7% | 加碼 | 歷史 |
| Bellus Health Inc New07987C204 | COM NEW | 4,346,700 | $4,590 萬 | 1.0% | +81,700+1.9% | 加碼 | – |
| RVMDRevolution Medicines, Inc. | COM | 2,321,200 | $4,577 萬 | 1.0% | +996,200+75.2% | 加碼 | 歷史 |
| Avidity Biosciences, Inc.05370A108 | COM | 2,600,000 | $4,246 萬 | 0.9% | +519,800+25.0% | 加碼 | – |
| JAZZJazz Pharmaceuticals plc | SHS USD | 318,300 | $4,243 萬 | 0.9% | +256,300+413.4% | 加碼 | 歷史 |
| ZLABZai Lab Ltd | ADR | 1,234,000 | $4,220 萬 | 0.9% | +1,234,000 | 新進 | 歷史 |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 1,255,374 | $4,149 萬 | 0.9% | −183,625−12.8% | 減碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 1,981,100 | $4,139 萬 | 0.9% | +1,981,100 | 新進 | 歷史 |
| DXCMDexcom Inc | COM | 467,600 | $3,766 萬 | 0.8% | +467,600 | 新進 | 歷史 |
| SYKStryker Corp | Stock | 184,700 | $3,741 萬 | 0.8% | +184,700 | 新進 | 歷史 |
| VERVVerve Therapeutics, Inc. | COM | 1,042,706 | $3,582 萬 | 0.8% | +1,042,706 | 新進 | 歷史 |
| ALTAltimmune, Inc. | COM NEW | 2,684,000 | $3,428 萬 | 0.7% | −297,000−10.0% | 減碼 | 歷史 |
| CNCCentene Corp | Stock | 432,400 | $3,365 萬 | 0.7% | +432,400 | 新進 | 歷史 |
| CRBUCaribou Biosciences, Inc. | COM | 3,172,600 | $3,347 萬 | 0.7% | +222,600+7.5% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | SPONSORED ADR | 563,200 | $3,089 萬 | 0.7% | −2,935,800−83.9% | 減碼 | 歷史 |
| NGMNGM Biopharmaceuticals Inc | COM | 1,798,100 | $2,352 萬 | 0.5% | +1,798,100 | 新進 | 歷史 |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 1,191,800 | $2,205 萬 | 0.5% | −8,200−0.7% | 減碼 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 2,820,000 | $2,180 萬 | 0.5% | +2,820,000 | 新進 | 歷史 |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,906,800 | $2,113 萬 | 0.5% | −13,000−0.7% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 1,357,700 | $2,026 萬 | 0.4% | +1,357,700 | 新進 | 歷史 |
| NKTXNkarta, Inc. | COM | 1,414,082 | $1,861 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| ONCBeOne Medicines Ltd. | ADR | 132,000 | $1,780 萬 | 0.4% | +132,000 | 新進 | 歷史 |
| SIBNSI-BONE, Inc. | COM | 996,700 | $1,740 萬 | 0.4% | −3,300−0.3% | 減碼 | 歷史 |
| GOSSGossamer Bio, Inc. | COM | 1,450,000 | $1,737 萬 | 0.4% | +1,450,000 | 新進 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 335,000 | $1,623 萬 | 0.4% | +335,000 | 新進 | 歷史 |
| ARQTArcutis Biotherapeutics, Inc. | COM | 794,500 | $1,518 萬 | 0.3% | +794,500 | 新進 | 歷史 |
| PCVXVaxcyte, Inc. | COM | 628,700 | $1,509 萬 | 0.3% | +628,700 | 新進 | 歷史 |
| ATECAlphatec Holdings, Inc. | COM NEW | 1,715,000 | $1,499 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| KNTEKinnate Biopharma Inc. | COM | 1,212,611 | $1,449 萬 | 0.3% | +1,212,611 | 新進 | 歷史 |
| IOVAIovance Biotherapeutics, Inc. | COM | 1,382,900 | $1,325 萬 | 0.3% | −9,400−0.7% | 減碼 | 歷史 |
| ANTXAN2 Therapeutics, Inc. | COM | 742,630 | $1,291 萬 | 0.3% | +54,300+7.9% | 加碼 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 1,303,600 | $1,289 萬 | 0.3% | +438,600+50.7% | 加碼 | 歷史 |
| TMDXTransMedics Group, Inc. | COM | 300,000 | $1,252 萬 | 0.3% | +300,000 | 新進 | 歷史 |
| SGMOQSangamo Therapeutics, Inc | COM | 2,360,800 | $1,157 萬 | 0.3% | +2,360,800 | 新進 | 歷史 |
| STOKStoke Therapeutics, Inc. | COM | 891,100 | $1,144 萬 | 0.2% | +891,100 | 新進 | 歷史 |
| SPNESeaSpine Holdings Corp | COM | 2,010,000 | $1,142 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| NSTGNS Wind Down Co., Inc. | COM | 698,200 | $891.6 萬 | 0.2% | +698,200 | 新進 | 歷史 |
| ERASErasca, Inc. | COM | 982,500 | $766.4 萬 | 0.2% | −12,500−1.3% | 減碼 | 歷史 |
| ALPNAlpine Immune Sciences, Inc. | COM | 998,600 | $719.0 萬 | 0.2% | +350.0% | 加碼 | 歷史 |
| SGRYSurgery Partners, Inc. | Stock | 267,600 | $626.2 萬 | 0.1% | +267,600 | 新進 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 900,000 | $579.6 萬 | 0.1% | +900,000 | 新進 | 歷史 |
| CMAXCareMax, Inc. | COM CL A | 755,329 | $535.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Medicus Sciences AcquisitionG5960S108 | CL A SHS | 520,000 | $514.8 萬 | 0.1% | 00.0% | 不變 | – |
| BCLS Acquisition CorpG0904B105 | COM CL A | 500,000 | $501.0 萬 | 0.1% | 00.0% | 不變 | – |
| LENZLENZ Therapeutics, Inc. | COM | 1,575,000 | $499.3 萬 | 0.1% | +865,000+121.8% | 加碼 | 歷史 |
| ARYDARYA Sciences Acquisition Corp IV | CL A | 500,000 | $495.5 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| Panacea Acquisition Corp. IIG6882C106 | CL A SHS | 500,000 | $490.0 萬 | 0.1% | 00.0% | 不變 | – |
| CMPXCompass Therapeutics, Inc. | COM | 2,000,000 | $456.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| EPIXESSA Pharma Inc. | COM NEW | 2,460,000 | $447.7 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| OBIOOrchestra BioMed Holdings, Inc. | ORD SHS | 400,000 | $396.0 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| CYTCyteir Therapeutics, Inc. | COM | 1,806,200 | $346.8 萬 | 0.1% | −43,800−2.4% | 減碼 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 813,700 | $294.6 萬 | 0.1% | +600.0% | 加碼 | 歷史 |
| SCYXScynexis Inc | COM NEW | 1,140,600 | $273.7 萬 | 0.1% | +181,076+18.9% | 加碼 | 歷史 |
| DNADSocial Capital Suvretta Holdings Corp. IV | CLASS A ORD SHS | 200,000 | $196.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| DNABSocial Capital Suvretta Holdings Corp. II | CLASS A ORD SHS | 200,000 | $196.0 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ONCSOncosec Medical Inc | COM | 2,945,000 | $143.7 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| HYPRHyperfine, Inc. | COM CL A | 1,503,754 | $121.8 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| ACIUAC Immune SA | SHS | 274,876 | $86.9 萬 | <0.1% | +274,876 | 新進 | 歷史 |
| Reunion Neuroscience Inc76134G103 | COM | 595,200 | $85.1 萬 | <0.1% | +595,200 | 新進 | – |
| WGSGeneDx Holdings Corp. | COMMON STOCK | 950,000 | $83.4 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| PHASPhaseBio Pharmaceuticals Inc | COM | 4,361,365 | $76.8 萬 | <0.1% | −43,635−1.0% | 減碼 | 歷史 |
| SNCEScience 37 Holdings, Inc. | COM | 430,000 | $69.2 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| Nuvation Bio Inc.67080N119 | *W EXP 07/07/202 | 99,999 | $1.80 萬 | <0.1% | 00.0% | 不變 | – |
| Medicus Sciences AcquisitionG5960S124 | *W EXP 02/12/202 | 57,770 | $1,000 | <0.1% | 00.0% | 不變 | – |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| SPDR Ser Tr78464A900 | CALL | – | $3.21 億 |
2022 年第 2 季之後清倉（15 檔）
2022 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2022 年第 2 季股數 | 2022 年第 2 季市值 | 2022 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| JNJJohnson & Johnson | Stock | 900,200 | $1.60 億 | 3.7% | 歷史 |
| MCKMcKesson Corp | Stock | 388,800 | $1.27 億 | 2.9% | 歷史 |
| UNHUnitedHealth Group Inc | Stock | 242,200 | $1.24 億 | 2.9% | 歷史 |
| ABBVAbbVie Inc. | Stock | 755,000 | $1.16 億 | 2.7% | 歷史 |
| LEGNLegend Biotech Corp | SPONSORED ADS | 1,000,000 | $5,500 萬 | 1.3% | 歷史 |
| ARK ETF Tr00214Q302 | GENOMIC REV ETF | 750,000 | $2,362 萬 | 0.5% | – |
| VIRVir Biotechnology, Inc. | COM | 758,211 | $1,931 萬 | 0.4% | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 4,855,000 | $1,573 萬 | 0.4% | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 450,000 | $1,369 萬 | 0.3% | 歷史 |
| SSentinelOne, Inc. | CL A | 204,500 | $477.1 萬 | 0.1% | 歷史 |
| ISEEIVERIC bio, Inc. | COM | 430,117 | $413.8 萬 | 0.1% | 歷史 |
| Field Trip Health Ord31656R102 | COM | 2,976,000 | $250.0 萬 | 0.1% | – |
| OTICOtonomy, Inc. | COM | 1,000,000 | $208.0 萬 | <0.1% | 歷史 |
| PROKProkidney Corp. | CLASS A ORD SHS | 200,000 | $199.0 萬 | <0.1% | 歷史 |
| AKLIAkili, Inc. | CLASS A ORD SHS | 200,000 | $197.8 萬 | <0.1% | 歷史 |